BBR can improve the effect of AD through various mechanisms, including inhibiting the hyperphosphorylation of Tau protein, inhibiting the production of Aβ, and inhibiting four key enzymes (acetylcholinesterase, butylcholinesterase and two isomers of monoamine oxidase) in the pathogenesis of AD. The gene discussed is MAPT; the disease is Alzheimer disease.